Annika Herlemann

1.8k total citations
75 papers, 1.1k citations indexed

About

Annika Herlemann is a scholar working on Pulmonary and Respiratory Medicine, Urology and Surgery. According to data from OpenAlex, Annika Herlemann has authored 75 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 19 papers in Urology and 17 papers in Surgery. Recurrent topics in Annika Herlemann's work include Prostate Cancer Diagnosis and Treatment (42 papers), Prostate Cancer Treatment and Research (38 papers) and Urinary Bladder and Prostate Research (19 papers). Annika Herlemann is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (42 papers), Prostate Cancer Treatment and Research (38 papers) and Urinary Bladder and Prostate Research (19 papers). Annika Herlemann collaborates with scholars based in Germany, United States and South Korea. Annika Herlemann's co-authors include Christian G. Stief, Christian Gratzke, Matthew R. Cooperberg, Samuel L. Washington, Peter R. Carroll, Peter Bartenstein, Alexander Kretschmer, Wolfgang P. Fendler, Vera Wenter and Kolja M. Thierfelder and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Annika Herlemann

67 papers receiving 1.1k citations

Peers

Annika Herlemann
Annika Herlemann
Citations per year, relative to Annika Herlemann Annika Herlemann (= 1×) peers Emanuele Zaffuto

Countries citing papers authored by Annika Herlemann

Since Specialization
Citations

This map shows the geographic impact of Annika Herlemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika Herlemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika Herlemann more than expected).

Fields of papers citing papers by Annika Herlemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annika Herlemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika Herlemann. The network helps show where Annika Herlemann may publish in the future.

Co-authorship network of co-authors of Annika Herlemann

This figure shows the co-authorship network connecting the top 25 collaborators of Annika Herlemann. A scholar is included among the top collaborators of Annika Herlemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annika Herlemann. Annika Herlemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pyrgidis, Nikolaos, Stephan Ledderose, Alexander Kretschmer, et al.. (2023). Characterization of Human Papilloma Virus in Prostate Cancer Patients Undergoing Radical Prostatectomy—A Prospective Study of 140 Patients. Viruses. 15(6). 1264–1264.
2.
Staehler, Michael, et al.. (2023). Long-Term Follow-Up in Patients Undergoing Renal Mass Biopsy: Seeding is not Anecdotal. Clinical Genitourinary Cancer. 22(2). 189–192. 4 indexed citations
3.
Herlemann, Annika, Janet E. Cowan, Samuel L. Washington, et al.. (2023). Long-term Prostate Cancer–specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. European Urology. 85(6). 565–573. 15 indexed citations
4.
Herlemann, Annika, Samuel L. Washington, Peter E. Lonergan, et al.. (2023). Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States. The World Journal of Men s Health. 41(4). 940–940. 4 indexed citations
5.
Siech, Carolin, Sophie Knipper, Annika Herlemann, et al.. (2023). Einflussfaktoren für die Berufszufriedenheit von Urologinnen – Ergebnisse einer Befragung der Deutschen Gesellschaft für Urologie e. V. (DGU). PubMed. 62(12). 1302–1308. 1 indexed citations
6.
Lonergan, Peter E., Chang Wook Jeong, Samuel L. Washington, et al.. (2021). Active surveillance in intermediate-risk prostate cancer with PSA 10–20 ng/mL: pathological outcome analysis of a population-level database. Prostate Cancer and Prostatic Diseases. 25(4). 690–693. 8 indexed citations
7.
Herlemann, Annika, et al.. (2021). RAS-NOTECHS: validity and reliability of a tool for measuring non-technical skills in robotic-assisted surgery settings. Surgical Endoscopy. 36(3). 1916–1926. 21 indexed citations
8.
Chaloupka, Michael, et al.. (2021). Nicht metastasiertes Prostatakarzinom: Wann und wie behandeln?. MMW - Fortschritte der Medizin. 163(7). 36–40. 2 indexed citations
9.
Mittlmeier, Lena M., Matthias Brendel, Leonie Beyer, et al.. (2021). Feasibility of Different Tumor Delineation Approaches for 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients. Frontiers in Oncology. 11. 663631–663631. 20 indexed citations
10.
Fasulo, Vittorio, Annika Herlemann, Alberto Saita, et al.. (2020). Clinical utility of biomarkers 4K score, SelectMDx and ExoDx with MRI for the detection of high-grade prostate cancer. European Urology Open Science. 19. e508–e509.
11.
Herlemann, Annika, Maya Overland, Samuel L. Washington, et al.. (2020). How Often Does Magnetic Resonance Imaging Detect Prostate Cancer Missed by Transrectal Ultrasound?. European Urology Focus. 7(6). 1268–1273. 3 indexed citations
12.
Li, Bingsheng, Qingfeng Yu, Christian Gratzke, et al.. (2020). Inhibition of Female and Male Human Detrusor Smooth Muscle Contraction by the Rac Inhibitors EHT1864 and NSC23766. Frontiers in Pharmacology. 11. 409–409. 13 indexed citations
13.
Chu, Carissa, Mohammed Alshalalfa, Martin Sjöström, et al.. (2020). Differential expression of PSMA and 18F-fluciclovine transporter genes in metastatic castrate-resistant and treatment-emergent small cell/neuroendocrine prostate cancer.. Journal of Clinical Oncology. 38(6_suppl). 24–24. 4 indexed citations
14.
Sievert, Karl‐Dietrich, Martin Schönthaler, R. Berges, et al.. (2018). Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years. World Journal of Urology. 37(7). 1353–1360. 43 indexed citations
15.
Schlenker, Boris, Annika Herlemann, Maria Apfelbeck, et al.. (2018). The increase of stage, grading, and metastases in patients undergoing radical prostatectomy during the last decade. World Journal of Urology. 37(6). 1103–1109. 5 indexed citations
16.
Schmidt-Hegemann, Nina-Sophie, Wolfgang P. Fendler, Harun Ilhan, et al.. (2018). Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy. Radiation Oncology. 13(1). 37–37. 50 indexed citations
17.
Herlemann, Annika, Janet E. Cowan, Peter R. Carroll, & Matthew R. Cooperberg. (2017). Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy. European Urology. 73(2). 215–223. 44 indexed citations
18.
Herlemann, Annika, Alexander Büchner, Alexander Kretschmer, et al.. (2017). Postoperative upgrading of prostate cancer in men ≥75 years: a propensity score-matched analysis. World Journal of Urology. 35(10). 1517–1524. 14 indexed citations
19.
Eapen, Renu, Annika Herlemann, Samuel L. Washington, & Matthew R. Cooperberg. (2017). Impact of the United States Preventive Services Task Force ‘D’ recommendation on prostate cancer screening and staging. Current Opinion in Urology. 27(3). 205–209. 38 indexed citations
20.
Herlemann, Annika & Christian G. Stief. (2016). Aktive Überwachung beim Niedrig-Risiko-Prostatakarzinom. Der Urologe. 55(2). 269–281. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026